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Abstract
Repeated exposure to drugs of abuse alters the structure and function of neural circuits mediating
reward, generating maladaptive plasticity in circuits critical for motivated behavior. Within mesocorticolimbic dopamine circuitry, repeated exposure to cocaine induces progressive alterations in
AMPAR-mediated glutamatergic synaptic transmission. During a 10–14 day period of abstinence from
cocaine, AMPAR signaling is potentiated at synapses on nucleus accumbens (NAc) medium spiny
neurons (MSNs), promoting a state of heightened synaptic excitability. Re-exposure to cocaine during
abstinence, however, rapidly reverses and depotentiates enhanced AMPAR signaling. To understand
how re-exposure to cocaine alters AMPAR synaptic transmission, we investigated the roles of
dopamine and endocannabinoid (eCB) signaling in modifying synaptic strength in the NAc shell. Using
patch-clamp recordings from NAc slices prepared after 10–14 days of abstinence from repeated
cocaine, we found that AMPAR-mediated depotentiation is rapidly induced in the NAc shell within
20 min of cocaine re-exposure ex vivo, and persists for up to five days before synapses return to levels
of potentiation observed during abstinence. In cocaine-treated animals, global dopamine receptor
activation was both necessary and sufficient for the cocaine-evoked depotentiation of AMPAR synaptic
function. Additionally, we identified that CB1 receptors are engaged by endogenous endocannabinoids
(eCBs) during re-exposure to cocaine ex vivo. Overall, these results indicate the central role that
dopamine and eCB signaling mechanisms play in modulating cocaine-induced AMPAR plasticity in the
NAc shell.

1. Introduction
Progressive functional changes in neural circuitry mediating learning and motivation are known to
underlie key behavioral hallmarks of drug addiction (Hyman et al., 2006, Thomas et al., 2008, Volkow
and Morales, 2015). A critical component of mesocorticolimbic circuitry governing reward-related
learning and motivated behavior, the nucleus accumbens (NAc) is a structure composed principally of
medium spiny neurons (MSNs) that receive converging input from midbrain dopaminergic afferents
and glutamatergic projections from cortical and limbic areas. Extensive experimental evidence
indicates that drugs of abuse engage endogenous mechanisms of neuronal plasticity to drive persistent
changes in synaptic transmission at NAc MSNs (Kauer and Malenka, 2007, Lüscher and Malenka, 2011).
This maladaptive form of plasticity has been well-demonstrated to underlie the development and
persistence of drug-seeking behavior in animal models of addiction (Wolf, 2016).
Accumulating evidence indicates that experience-dependent alterations in glutamate transmission in
the NAc, such as those produced by repeated exposure to cocaine, involve alterations in postsynaptic
signaling mediated by AMPA-type receptors (Pierce and Wolf, 2013, Wolf and Ferrario, 2010). In the
NAc shell, repeated cocaine exposure results in a progressive increase in MSN AMPAR signaling during
abstinence that heightens sensitivity to glutamatergic input, and is a key factor in the development and
persistence of addiction-related behavior such as behavioral sensitization, craving, and relapse
(Boudreau and Wolf, 2005, Conrad et al., 2008, Kourrich et al., 2007, Pascoli et al., 2014, Pascoli et al.,
2011, Terrier et al., 2016). Conversely, additional studies citing both biochemical (Boudreau et al.,
2007, Ferrario et al., 2009) and physiological evidence (Kourrich et al., 2007; et al., 2011) have shown

that exposure to relapse-inducing stimuli such as stress or a cocaine challenge injection reverses
(depotentiates) cocaine-dependent increases in NAc shell AMPAR signaling, suggesting that this
reversal of plasticity may play a role in driving this behavior. While the ability of relapse-inducing
stimuli to bidirectionally modify NAc AMPAR signaling has been demonstrated on numerous occasions,
the cellular mechanisms underlying this plasticity remain unclear.
Within the striatum, pre- and postsynaptic neuromodulatory signaling plays a critical role in gating
changes in MSN glutamatergic synaptic strength (Lerner and Kreitzer, 2011). Prominent among these
modulators is dopamine (DA), which is known to regulate MSN intrinsic and synaptic excitability (Nicola
et al., 2000, Tritsch and Sabatini, 2012). Moreover, activation of DA D1 or D2 receptors in the NAc shell
reinstates cocaine seeking (Schmidt and Pierce, 2006), whereas activation of D1Rs during abstinence
normalizes cocaine-induced increases in AMPAR-mediated synaptic transmission (Ortinski et al., 2012),
highlighting a potential role for DA receptors in the depotentiation of AMPAR synaptic strength
observed in the NAc shell following cocaine re-exposure.
Similar to the striatal DA system, neurotransmission mediated by the endocannabinoid (eCB) system
powerfully modulates synaptic efficacy at NAc glutamatergic synapses (Lovinger and Mathur, 2012,
Piet et al., 2011, Robbe et al., 2003). Induction of eCB signaling requires post-synaptic release of eCBs
which then signal retrogradely at pre-synaptic cannabinoid type 1 (CB1) receptors, depressing
neurotransmitter release (Hoffman and Lupica, 2001, Kano et al., 2009). Throughout the striatum and
other brain regions, eCB signaling mediates various forms of short-term and long-term synaptic
depression, comprising a dominant mechanism for reducing synaptic strength at excitatory synapses
(Lüscher and Huber, 2010). Recent evidence implicating NAc CB1 signaling in cocaine-primed
behavioral sensitization and reinstatement (McReynolds et al., 2016, Ramiro-Fuentes and FernandezEspejo, 2011, Xi et al., 2006) makes this system a prime candidate in modulating cocaine-dependent
reversal of AMPAR signaling in the NAc; however, our understanding of how repeated cocaine engages
and alters eCB-mediated synaptic plasticity in the NAc remains relatively incomplete. The present study
investigated the temporal dynamics and potential cellular mechanisms underlying cocaine-induced
depotentiation of AMPAR signaling in the NAc, focusing on potential roles for dopamine and eCB
signaling using in vivo and ex vivo approaches.

2. Materials and methods
2.1. Animals
Adult male (P49-70) C57BL/6 mice (Jackson Laboratories, Bar Harbor, Maine, USA) were used. All
animals were group-housed in a temperature- and humidity-controlled environment on a 12 h
light/12 h dark cycle, with food and water available ad libitum. All experiments were approved by the
Institutional Animal Care and Use Committee at the University of Minnesota.

2.2. Behavioral sensitization
Prior to testing, mice were habituated to experimenter handling, i.p. injections, and the testing
environment (individual activity boxes, 8.5 × 17.5 x 9 in) over two days. On five consecutive testing

days, mice were habituated to the testing environment for 30 min (min) before receiving an
intraperitoneal injection of either cocaine (15 mg/kg) or saline. Mice were immediately placed back
into the testing environment, and their activity was monitored for 90 min using a video-based tracking
system (Any-Maze, Stoelting, WI, USA). Animals were returned to their home cages at the end of each
testing period. Following the last day of testing, animals remained in their home cages in the colony for
10–14 days before electrophysiology experiments were performed. For in vivo drug challenge
experiments only, mice were handled and injected with saline during the last 2 days of the 10–14 day
abstinence period to prevent any potential effects of stress during the challenge experiment. Mice
were habituated to the testing environment for 30 min before receiving a challenge injection of
cocaine (15 mg/kg) or saline, followed by activity monitoring for 90 min. Electrophysiology experiments
took place within 24 h (h) or 5 days (d) following the challenge injection.

2.3. Slice electrophysiology
Following 10–14 days of abstinence from cocaine treatment or either 24 h or 5 d after an in vivo
cocaine challenge injection, mice were anesthetized with isoflurane, decapitated, and the brain rapidly
removed. Parasagittal slices (240 μm) containing the nucleus accumbens shell were prepared in 2–4 °C
sucrose-containing artificial cerebrospinal fluid (ACSF) saturated with 95% O2/5% CO2 and composed of
(in mM): 75 sucrose, 87 NaCl, 2.5 KCl, 1.25 NaH2PO4, 26 NaHCO3, 11 glucose, 7 MgSO4, 0.5 CaCl2, and 3
sodium ascorbate (Britt et al., 2012). Slices rested for at least 30 min in a holding chamber at room
temperature containing standard ACSF composed of (in mM): 119 NaCl, 2.5 KCl, 1.0 NaH2PO4, 26.2
NaHCO3, 11 glucose, 1.3 MgSO4, 2.5 CaCl2, and 1 sodium ascorbate. During recording, standard ACSF
was used with the exception of the sodium ascorbate. Additionally, picrotoxin (100 μM) and lidocaine
(0.7 μM) were included to block GABAA-mediated inhibitory transmission and action potentials,
respectively, during recording. Neurons in the NAc shell were visualized on an upright microscope
using infrared differential interference contrast (IR-DIC) optics. MSNs were identified by their
morphology and hyperpolarized resting membrane potential (−70 to −80 mV). To assess excitatory
synaptic transmission, cells were voltage-clamped at −80 mV using an Axon Instruments MultiClamp
700A (Molecular Devices, Sunnyvale, CA, USA). Patch pipettes (3–5 MΩ) were filled with a cesiumgluconate-based internal solution containing (in mM): 117 cesium gluconate, 2.8 NaCl, 20 HEPES, 0.4
EGTA, 5 tetraethylammonium-Cl, 2 MgATP, and 0.3 MgGTP (pH 7.2–7.4). Data were filtered at 2 kHz,
digitized at 5 kHz, and collected using custom Igor Pro software (Wavemetrics, Lake Oswego, OR, USA).
A depolarizing step (4 mV, 100 ms) was generated at the beginning of each sweep to monitor series
resistance (10–40 MΩ) and input resistance (>500 MΩ). MiniAnalysis software (Synaptosoft, Decatur,
GA, USA) was used offline to analyze mEPSC amplitude, frequency, rise time, and decay time. To
determine the rise time and decay time, two exponentials were fit to the rise time or decay time of
mEPSCs using the MiniAnalysis curve-fitting function, and the time constant was calculated between 10
and 90% of peak.

2.4. Ex vivo drug application
Drugs were prepared in a stock solution and added at the final concentration to the ACSF perfusing the
slices. A between-cell experimental design was utilized in which slices were bathed in the drug or

control ACSF prior to recording synaptic activity. During these experiments, slices were exposed to one
of the following conditions: 1) no challenge (exposure to ACSF only); 2) ex vivo cocaine challenge
(10 μM; 10 min); 3) ex vivo bath application of flupenthixol (non-specific dopamine receptor
antagonist; 20 μM; 10 min) or SR141716A (CB1 antagonist/inverse agonist; 1 μM; 10 min) alone; 4)
ex vivo bath application of flupenthixol or SR141716A alone (10 min) followed by flupenthixol or
SR141716A in the presence of 10 μM cocaine (10 min); or 5) ex vivo bath application of apomorphine
(non-specific dopamine receptor agonist; 1 μM; 10 min) or WIN 55,212-2 (CB1 receptor agonist; 1 μM;
20 min) alone. Following the timed ex vivo drug exposure(s), the perfusion was switched back to
standard ACSF for recording. Recordings took place up to 1 h following ex vivo drug exposure, and the
time elapsed between drug exposure and beginning a recording was noted to determine whether time
following drug exposure was a factor in synaptic plasticity.

2.5. Drugs
Apomorphine, flupenthixol, SR141716A, and WIN 55,212-2 were purchased from Tocris Bioscience
(Bristol, United Kingdom). Lidocaine and picrotoxin were purchased from Sigma Aldrich (St. Louis, MO,
USA). Cocaine was obtained from Boynton Health Services Pharmacy (University of Minnesota,
Minneapolis, MN, USA). Drugs were prepared in a stock solution at 100–1000 times the desired
concentration and added into standard ACSF at the final concentration. SR141716A stock was dissolved
in DMSO, and WIN 55,212-2 stock was dissolved in ethanol. The final concentrations of DMSO or
ethanol were <0.01%.

2.6. Statistical analysis
All data are presented as group mean ± SEM. Statistical significance was assessed with a Student's ttest, one-way ANOVA, or two-way ANOVA using JMP Pro (SAS, Cary, NC, USA) and GraphPad Prism
(GraphPad Software, La Jolla, CA, USA). Tukey HSD post hoc tests were used for pairwise comparisons
where appropriate. The threshold for significance was p < 0.05.

3. Results
3.1. Depotentiation of AMPAR synaptic transmission induced by cocaine re-exposure is
rapidly induced and temporally constrained
Previous studies examining cocaine-induced AMPAR plasticity in the NAc have shown that the ability of
intra-NAc AMPA to induce locomotor activity is decreased 24 h but not 6 d following a cocaine
challenge (Bachtell and Self, 2008), indicating that cocaine challenge-induced plasticity in the NAc is
transient in nature. To investigate the duration of AMPAR synaptic plasticity in the NAc shell, we
performed ex vivo recordings of mEPSCs, a direct measure of synaptic AMPAR function, 24 h or 5 d
following a cocaine challenge injection (given on day 10–14 of abstinence). Twenty-four hours
following cocaine challenge, mEPSC amplitude (picoamperes of current, pA) and frequency (events per
second, Hz) were significantly reduced compared to cocaine-treated animals receiving a saline
challenge [amplitude (Fig. 1C-left): Sal (11.29 ± 0.40); Coc (14.50 ± 0.97); Coc-coc 24h (10.84 ± 0.42);

F(3,29) = 7.72, p = 0.0006); frequency (Fig. 1C-right): Sal (3.80 ± 0.44); Coc (5.52 ± 0.30); Coc-coc 24h
(3.55 ± 0.28); F(3,29) = 6.04, p = 0.0026]. However, 5 d following in vivo cocaine challenge, neither mEPSC
amplitude (14.60 ± 0.89) nor frequency (5.93 ± 0.80) were significantly different from cocaine-treated
controls receiving no challenge injection. Additionally, no differences in AMPAR mEPSC rise time
kinetics [Sal (3.26 ± 0.35); Coc (2.70 ± 0.14); Coc-coc 24h (3.33 ± 0.10); Coc-coc 5d (3.00 ± 0.10);
F(3,20) = 0.73, p = 0.55) or decay time kinetics [Sal (3.24 ± 0.19); Coc (3.73 ± 0.15); Coc-coc 24h
(3.93 ± 0.30); Coc-coc 5d (3.93 ± 0.21); F(3,20) = 2.31, p = 0.11] were observed.

Fig. 1. Cocaine-induced potentiation of AMPAR synaptic transmission in the NAc shell is reversed by
in vivo cocaine challenge and persists for up to 4 days post challenge.
(A) Experimental timeline. Following 5 days of saline or cocaine (5 mg/kg; i.p.) injections and a 10–14 d
abstinence period, animals received a single challenge injection of cocaine. Electrophysiological
recordings were performed either during abstinence, 24 h following a challenge injection, or 5 d
following a challenge injection. (B) Representative miniature excitatory postsynaptic current (mEPSC)
traces from NAc shell neurons from saline + no challenge (Sal), cocaine + no challenge (Coc - no
challenge), cocaine + cocaine challenge at 24h (Coc – 24h), and cocaine + cocaine challenge at 5d (Coc
– 5d). (C) Mean mEPSC amplitude (pA; left) and frequency (Hz; right) in the NAc shell from saline + no
challenge (Sal, white; n = 7, N = 3), cocaine + no challenge (Coc, gray; n = 8, N = 5), cocaine + cocaine
challenge at 24h (Coc-coc 24h, black; n = 9, N = 3); cocaine + cocaine challenge at 5d (Coc-coc 5d,
green; n = 9, N = 3). (D) Cumulative probability distributions of mEPSC amplitude (pA; left) and interevent interval (ms; right) from saline + no challenge (Sal, light gray), cocaine + no challenge (Coc-sal,
medium gray), cocaine + cocaine challenge at 24h (Coc-coc 24h, black), cocaine + cocaine challenge at

5d (Coc-coc 5d, green). All data are presented as mean ± SEM. n, number of cells; N, number of
animals. *p ≤ 0.05 vs. Coc, **p ≤ 0.01 vs Coc; #p ≤ 0.05 vs Coc-coc 5d, ##p ≤ 0.01 vs Coc-coc 5d.
Studies investigating cocaine-induced reversal of synaptic potentiation in the NAc have
characteristically observed synaptic plasticity at 2–24 h following in vivo cocaine challenge injection,
leaving open the question of how rapidly plasticity is induced by cocaine re-exposure (Bachtell and Self,
2008, Boudreau et al., 2007, Kourrich et al., 2007, Rothwell et al., 2011). To examine this, we utilized a
recently developed ex vivo model of cocaine re-exposure which our lab has shown reverses the
increase in NAc shell AMPAR transmission produced by repeated in vivo cocaine exposure (Jedynak
et al., 2016). Following bath application of cocaine, recordings of mEPSCs were performed in the NAc
shell for up to 1 h, with cells binned into 20-, 40-, and 60-min groups based on the time elapsed
between cocaine challenge and recording. Consistent with previous studies (Jedynak et al., 2016,
Kourrich et al., 2007), the amplitude and frequency of mEPSCs were significantly elevated in MSNs
from cocaine-treated animals in the NAc shell, indicating potentiation of AMPAR synaptic transmission
during abstinence [amplitude (Fig. 2C-left): Coc (13.65 ± 0.38); frequency (Fig. 2C-right): Coc
(6.8 ± 0.58)]. Following ex vivo challenge at all time intervals, we observed a significant decrease in
mEPSC amplitude and frequency, with a ∼30% reduction in AMPAR-mediated signaling observed
equally at all three post-challenge timepoints [amplitude (Fig. 2C-left): 20 min (9.62 ± 0.40); 40 min
(10.30 ± 0.65); 60 min (10.46 ± 0.60); F(3,46) = 14.36, p < 0.0001; frequency (Fig. 2C-right): 20 min
(3.95 ± 0.49); 40 min (3.44 ± 0.22); 60 min (3.44 ± 0.37); F(3,46) = 9.03, p < 0.0001]. No differences in rise
time kinetics (milliseconds, ms) [Coc (3.29 ± 0.08); 20 min (3.53 ± 0.19); 40 min (3.60 ± 0.20); 60 min
(3.58 ± 0.23); F(3,32) = 1.21, p = 0.32) or decay time kinetics (milliseconds, ms) [Coc (4.11 ± 0.15); 20 min
(4.12 ± 0.21); 40 min (3.72 ± 0.38); 60 min (4.24 ± 0.36); F(3,34) = 0.62, p = 0.61] of AMPAR mEPSCs were
observed. Taken together, these results demonstrate that in cocaine-experienced animals, re-exposure
to cocaine after a period of abstinence reverses the cocaine-elicited potentiation of AMPAR-mediated
signaling on a rapid timescale (less than 20 min), but the reduction in AMPAR synaptic transmission is
constrained to a time window of 1–5 days before synapses return to a potentiated state.

Fig. 2. Ex vivo cocaine re-exposure induces depotentiation of AMPAR signaling in the NAc shell that is
maximally expressed within 20 min post challenge.
(A) Experimental timeline. Following 10–14 days of abstinence from repeated saline or cocaine
(5 mg/kg; i.p.) injections, electrophysiological recordings were performed in acute slices receiving 1) no
bath challenge (ACSF only) or 2) ex vivo cocaine (10 μM; 10 min), with recordings taking place at 20, 40,
or 60 min following the initial 10 min bath challenge. (B) Representative miniature excitatory

postsynaptic current (mEPSC) traces from NAc shell neurons from saline + no challenge (Sal),
cocaine + no challenge (Coc - no challenge), cocaine + cocaine challenge at 20 min (Coc-coc + 20),
cocaine + cocaine challenge at 40 min (Coc-coc + 40), and cocaine + cocaine challenge at 60 min (Coccoc + 60). (C) Mean mEPSC amplitude (pA; left) and frequency (Hz; right) in the NAc shell from
cocaine + no challenge (Coc, gray; n = 23, N = 19), cocaine + cocaine 20 min post challenge (Coc-coc 20,
light green; n = 7, N = 7), cocaine + cocaine 40 min post challenge (Coc-coc 40, medium green; n = 6,
N = 6), cocaine + cocaine 60 min post challenge (Coc-coc 60, dark green; n = 6, N = 6). (D) Cumulative
probability distributions of mEPSC amplitude (pA; left) and inter-event interval (ms; right) from
cocaine + no challenge (Coc-sal, gray), cocaine + cocaine 20 min post challenge (Coc-coc + 20, light
green), cocaine + cocaine 40 min post challenge (Coc-coc + 40, medium green), cocaine + cocaine
60 min post challenge (Coc-coc + 60, dark green). All data are presented as mean ± SEM. n, number of
cells; N, number of animals. **p ≤ 0.01 vs. Coc, ***p ≤ 0.001 vs Coc.

3.2. Dopamine receptor activation is necessary and sufficient for cocaine-induced
synaptic depotentiation
In the striatum, dopamine plays a critical role in regulating the induction of synaptic plasticity by
modulating excitatory synaptic transmission through several mechanisms, including modification of
post-synaptic neurotransmitter receptors (O'Donnell, 2003, Surmeier et al., 2007, Tritsch and Sabatini,
2012). Several studies indicate that dopamine receptor activation promotes increased surface
expression of MSN AMPARs (Snyder et al., 2000, Wolf, 2010). Thus, we hypothesized that dopamine
receptor activation provoked by cocaine re-exposure might participate in the reversal of enhanced
AMPAR synaptic transmission in the NAc shell. To examine this, we applied the non-specific dopamine
antagonist flupenthixol ex vivo prior to cocaine challenge to determine whether dopamine receptor
activation is necessary for the induction of AMPAR synaptic depotentiation. A non-specific dopamine
receptor antagonist was chosen for these studies, as our goal was to assess AMPAR function in NAc
MSN subpopulations as a whole, rather than differentiate between effects that may selectively occur
on MSNs expressing select DA receptor sub-types. As previously demonstrated, abstinence (10–14 d)
from repeated cocaine potentiated mEPSC amplitude, which was reversed by ex vivo cocaine bath
challenge [Fig. 3C-left: Sal (10.19 ± 0.53); Coc (13.09 ± 0.46); Coc-coc (10.04 ± 0.40); F(4,37) = 10.39,
p < 0.0001]. Similarly, mEPSC frequency was increased during withdrawal from cocaine but reversed by
ex vivo cocaine challenge [Fig. 3C-right: Sal (4.08 ± 0.53); Coc (6.87 ± 0.84); Coc-coc (4.23 ± 0.42);
F(4,37) = 4.59, p = 0.0041]. However, bath application of flupenthixol (20 μM) prior to ex vivo cocaine
challenge blocked the cocaine-induced reduction in mEPSC amplitude (12.42 ± 0.70) and frequency
(6.410 ± 0.86). Exposure to flupenthixol alone had no baseline effects on mEPSC amplitude or
frequency in saline-treated (amplitude: 10.53 ± 0.89; frequency: 4.81 ± 0.76) or cocaine-treated
animals (amplitude: 12.08 ± 0.64; frequency: 5.36 ± 0.67). In addition, there were no differences in the
rise time kinetics [Sal (3.28 ± 0.14); Coc (3.18 ± 0.08); Coc-coc (3.61 ± 0.19); Coc-Flp-coc (3.31 ± 0.13);
F(4,34) = 1.70, p = 0.17) or decay time kinetics [Sal (3.62 ± 0.22); Coc (3.89 ± 0.16); Coc-coc (3.79 ± 0.27);
Coc-Flp-coc (4.17 ± 0.23); F(4,34) = 0.80, p = 0.53] of AMPAR mEPSCs evident among the groups.

Fig. 3. Dopamine receptor activation is required for depotentiation of NAc shell AMPAR signaling
induced by ex vivo cocaine re-exposure.
(A) Experimental timeline. Following 10–14 days of abstinence from repeated saline or cocaine
(5 mg/kg; i.p.) injections, electrophysiological recordings were performed in acute slices receiving 1) no
bath challenge (ACSF only); 2) ex vivo cocaine challenge (10 μM; 10 min); 3) ex vivo bath application of
the dopamine receptor antagonist flupenthixol (20 μM; 10 min) followed by 10 μM

cocaine + flupenthixol (10 min); or 4) ex vivo bath application of the dopamine receptor agonist
apomorphine (1 μM). (B) Representative miniature excitatory postsynaptic current (mEPSC) traces
from NAc shell neurons from saline + no challenge (Sal), cocaine + no challenge (Coc - no challenge),
cocaine + cocaine challenge (Coc-coc), cocaine + flupenthixol/cocaine (Coc-Flp-coc),
cocaine + apomorphine (Coc-Apo). C) Mean mEPSC amplitude (pA; left) and frequency (Hz; right) in the
NAc shell from saline + no challenge (Sal, white; n = 8; N = 6), cocaine + no challenge (Coc, gray; n = 10,
N = 11), cocaine + cocaine challenge (Coc-coc, red; n = 9, N = 7), cocaine + flupenthixol/cocaine (CocFlp-coc, blue; n = 7, N = 5), cocaine + apomorphine (Coc-Apo, black; n = 6, N = 4). (D) Cumulative
probability distributions of mEPSC amplitude (pA; left) and inter-event interval (ms; right) from
cocaine + no challenge (Coc-sal, gray), cocaine + cocaine challenge (Coc-coc, red),
cocaine + flupenthixol/coc (Coc-Flp-coc, blue), cocaine + apomorphine (Coc-Apo, black). All data are
presented as mean ± SEM. n, number of cells; N, number of animals. *p ≤ 0.05 vs. Coc, **p ≤ 0.01 vs.
Coc, ***p ≤ 0.001 vs Coc; #p ≤ 0.06 vs. Coc-Flp-coc, ##p ≤ 0.01 vs. Coc-Flp-coc.
Given that activation of DA receptors has been shown to mediate the induction of striatal LTD
(Calabresi et al., 2007, Kreitzer and Malenka, 2005), we next investigated whether dopamine receptor
activation is sufficient to drive reductions in AMPAR signaling produced by cocaine and subsequent
abstinence. Ex vivo application of the non-specific dopamine receptor agonist apomorphine (1 μM)
reduced mEPSC amplitude (Fig. 3C-left; 9.33 ± 0.40) and frequency (Fig. 3C-right; 3.61 ± 0.36)
compared to cocaine + no challenge controls. Apomorphine application in saline animals had no effect
on baseline mEPSC amplitude (9.62 ± 0.63) or frequency (3.37 ± 0.61). AMPAR mEPSC rise time
(3.56 ± 0.21) and decay time kinetics (3.91 ± 0.26) were unchanged by apomorphine. Taken together,
these data demonstrate that dopamine receptor activation is both necessary and sufficient for AMPAR
synaptic depotentiation elicited by re-exposure to cocaine, demonstrating a central role for dopamine
receptors in mediating this form of plasticity.

3.3. Activation of CB1 receptors drives cocaine-induced synaptic depotentiation
Within the NAc, endogenous cannabinoids play a central role in modulating glutamatergic synaptic
transmission (Lüscher and Huber, 2010, Robbe et al., 2002). Located predominantly on axon terminals
contacting MSNs, activation of CB1 receptors leads to suppression of presynaptic transmitter release
following activation of postsynaptic signaling (Hoffman and Lupica, 2001, Robbe et al., 2001, Robbe
et al., 2003). To test whether CB1 receptor activation mediates cocaine-induced reductions in AMPAR
synaptic transmission, we bath applied the CB1 antagonist/inverse agonist SR141716A during an
ex vivo cocaine challenge. While bath application of SR141716A (1 μM) in the presence of ex vivo
cocaine produced a modest blockade of the cocaine-induced reductions in mEPSC amplitude (Fig. 4Cright; Sal (10.32 ± 0.35); Coc (14.17 ± 0.59); Coc-coc (9.76 ± 0.52); F(4,48) = 11.31, p < 0.0001), it robustly
blocked the decrease in mEPSC frequency (Fig. 4C-right; Sal (3.50 ± 0.38); Coc (6.73 ± 0.82); Coc-coc
(3.26 ± 0.28); Coc-SR-coc (6.36 ± 0.62); F(4,48) = 6.73, p = 0.0002). No changes in AMPAR rise time
kinetics [Sal (3.75 ± 0.17); Coc (3.30 ± 0.09); Coc-coc (3.53 ± 0.17); Coc-SR-coc (3.18 ± 0.16) or decay
time kinetics [Sal (5.10 ± 0.32); Coc (4.36 ± 0.23); Coc-coc (4.33 ± 0.27); Coc-SR-coc (4.01 ± 0.26) were
observed. Bath application of SR141716A slightly elevated baseline mEPSC frequency in both saline and
cocaine pre-treated animals, but this effect was not significant [Sal-SR (5.09 ± 1.12); Coc-SR
(7.91 ± 1.36), not shown].

Fig. 4. Activation of CB1 receptors is required for reversal of NAc shell AMPAR potentiation induced
by ex vivo cocaine re-exposure.
(A) Experimental timeline. Following 10–14 days of abstinence from repeated saline or cocaine
(5 mg/kg; i.p.) injections, electrophysiological recordings were performed in acute slices receiving 1) no
bath challenge (ACSF only); 2) ex vivo cocaine challenge (10 μM; 10 min); 3) ex vivo bath application of

the CB1 receptor antagonist SR141716A (1 μM; 10 min) followed by 10 μM cocaine + SR141716A
(10 min); or 4) ex vivo bath application of CB1 receptor agonist WIN 55,212-2 (1 μM). (B)
Representative miniature excitatory postsynaptic current (mEPSC) traces from NAc shell neurons from
saline + no challenge (Sal), cocaine + no challenge (Coc - no challenge), cocaine + cocaine challenge
(Coc-coc), cocaine + SR141716A/cocaine (Coc-SR-coc), cocaine + WIN 55,212-2 (Coc-Win). C) Mean
mEPSC amplitude (pA; left) and frequency (Hz; right) in the NAc shell from saline + no challenge (Sal,
white; n = 8, N = 7), cocaine + no challenge (Coc, gray; n = 12, n = 9), cocaine + cocaine challenge (Coccoc, red; n = 10, N = 6), cocaine + SR141716A/cocaine (Coc-SR-coc, blue; n = 15, N = 9), cocaine + WIN
55,212-2 (Coc-Win, black; n = 8, N = 4). (D) Cumulative probability distributions of mEPSC amplitude
(pA; left) and inter-event interval (ms; right) from cocaine + no challenge (Coc-sal, gray),
cocaine + cocaine challenge (Coc-coc, red), cocaine + SR141716A/coc (Coc-SR-coc, blue), cocaine + WIN
55,212-2 (Coc-Win, black). All data are presented as mean ± SEM. n, number of cells; N, number of
animals. *p ≤ 0.05 vs. Coc, **p ≤ 0.01 vs. Coc, ***p ≤ 0.001 vs Coc, ****p ≤ 0.0001; #p ≤ 0.06 vs. CocSR-coc, ##p ≤ 0.01 vs. Coc-SR-coc.
We next asked whether activation of CB1 receptors is sufficient to induce synaptic depotentiation in
the NAc shell. While several studies have reported that activation of CB1 receptors in the striatum is
sufficient to induce eCB-mediated LTD (Kreitzer and Malenka, 2005, Robbe et al., 2001), it is not clear
whether these mechanisms remain intact or are altered following cocaine exposure. To investigate
this, we substituted the ex vivo cocaine challenge with bath application of the CB1 receptor agonist
WIN 55,212-2 ex vivo. Application of WIN 55,212-2 (1 μM) was sufficient to induce depotentiation of
mEPSC amplitude (Fig. 4C-left; 9.69 ± 0.25) and frequency (Fig. 4C-right; 3.99 ± 0.73) in slices from
animals abstinent from cocaine, without altering basal mEPSC amplitude (10.38 ± 0.72) or frequency
(3.38 ± 0.51) in saline-treated animals. No changes in mEPSC rise time (3.72 ± 0.23) or decay time
(4.76 ± 0.27) kinetics were detected. Our results demonstrate that activating CB1 receptors during
abstinence from repeated cocaine is sufficient to depotentiate AMPAR-mediated synaptic transmission
in the NAc.

4. Discussion
The current study investigated the temporal and mechanistic profile of bidirectional AMPAR plasticity
in the NAc shell following re-exposure to cocaine during abstinence. We demonstrate that 1) enhanced
AMPAR signaling produced by repeated cocaine is rapidly reversed by in vivo and ex vivo cocaine reexposure and persists up to 4 d post challenge injection, and 2) that both endogenous dopamine and
eCB signaling play necessary roles in the cocaine challenge-induced depotentiation of AMPAR synaptic
transmission.

4.1. Cocaine-induced reversal of AMPAR synaptic strength is temporally constrained
Data from our lab and others has established that a single cocaine re-exposure during late abstinence
reverses the enhanced AMPAR synaptic potentiation that develops during a period of abstinence from
repeated cocaine, demonstrating the ability of cocaine to bidirectionally modulate synaptic strength at

NAc MSNs (Jedynak et al., 2016, Kourrich et al., 2007, Pascoli et al., 2011, Rothwell et al., 2011).
However, the temporal dynamics of this plasticity were not well-defined.
Numerous studies have demonstrated that repeated exposure to cocaine promotes a time-dependent
enhancement of AMPAR plasticity in the NAc that progresses as withdrawal becomes more protracted
(Boudreau and Wolf, 2005, Conrad et al., 2008, Kourrich et al., 2007, Pascoli et al., 2014, Terrier et al.,
2016). Our data indicate that, unlike progressive increases in AMPAR signaling, re-exposure to cocaine
produces rapid-onset plasticity that culminates in reversal of potentiated AMPAR signaling and is
maximally expressed within 20 min, as further reductions are not observed at 60 min or 24 h. However,
within 5 days of the challenge injection, AMPAR synaptic transmission returns to a pre-challenge state
that is indistinguishable from MSNs from animals in abstinence from cocaine, suggesting that synapses
undergoing AMPAR-mediated depotentiation by cocaine re-exposure are effectively “repotentiated.”
Consistent with this, previous work has shown that the ability of an intra-NAc infusion of AMPA to
augment locomotor activity is abolished within 24 h, but not 6 d following cocaine challenge (Bachtell
and Self, 2008), and NAc surface expression of AMPARs is decreased 24 h after cocaine challenge but
returns to pre-challenge levels of expression after 7 d abstinence (Ferrario et al., 2009).
Within the striatum, short-term and long-lasting reductions in excitatory synaptic strength are
commonly expressed through rapid internalization of AMPARs (Lüscher and Huber, 2010, Snyder et al.,
2001). The opposing alterations in AMPAR trafficking may simply serve as a homeostatic regulatory
mechanism counteracting shifts in glutamatergic signaling induced by cocaine exposure. For example,
synaptic expression of AMPARs may reflect a compensatory response to decreased extracellular
glutamate and synaptic excitability that develops during extended abstinence from cocaine(Baker
et al., 2003, Kourrich and Thomas, 2009, Kourrich et al., 2007), while removal of AMPARs from the
synapse might offset the rapid increase in glutamate elicited by re-exposure to cocaine(Kalivas et al.,
2005). Although the functional relevance of bidirectional alterations in AMPAR plasticity is unclear,
these findings highlight the existence of multiple forms of plasticity at NAc synapses that likely serve to
regulate and update synaptic strength as a consequence of varied drug experiences that may underlie
relapse susceptibility.

4.2. Dopamine modulation of enhanced AMPAR synaptic transmission
Exposure to cocaine in vivo (Di Chiara and Imperato, 1988) and ex vivo (Hoffmann et al., 2012, Kelly
and Wightman, 1987) increases the synaptic availability of dopamine within the NAc. In the present
study, the ability of both DA receptor antagonists to block cocaine-induced short-term plasticity and
receptor agonists to suppress excitatory signaling in a manner indistinguishable from ex vivo or in vivo
cocaine (Jedynak et al., 2016) demonstrates that transient activation of endogenous dopamine
signaling in the NAc shell is both necessary and sufficient for cocaine challenge-induced suppression of
AMPAR plasticity. Notably, it is unclear exactly how cocaine augments endogenous DA in our ex vivo
conditions; however, spontaneous DA transients mediated by exocytotic release events have been
observed in striatal slice preparations (Beckstead et al., 2004, Gantz et al., 2013, Zhou et al., 2001), and
acute ex vivo cocaine has been shown to increase the frequency and amplitude of dopamine transients
in the NAc through activation of nicotinic receptors, indicating the involvement of cholinergic
interneurons (Yorgason et al., 2017).

The effects of dopamine receptor activity on AMPAR signaling in the NAc are likely to be varied and
complex, given that dopamine receptor activation is capable of bidirectionally modifying excitatory
synaptic strength depending on the dopamine receptor subtype and location, MSN cell subtype, level
of synaptic activity, as well as previous drug experience (Tritsch and Sabatini, 2012, Wang et al., 2012).
Previous work has shown that cooperative activation of dopamine D1 and D2 receptors in the NAc
shell is necessary for cocaine-primed reinstatement, while individual blockade of either receptor
subtype disrupts this behavior (Anderson et al., 2005, Anderson et al., 2003, Bachtell et al., 2005,
Schmidt et al., 2006), suggesting that increased extracellular dopamine elicited by cocaine might
participate in modifying excitatory synaptic strength in the NAc shell during cocaine re-exposure.
Because data from this study and previous work (Kourrich et al., 2007, Jedynak et al., 2016; et al.,
2011) were collected from pooled populations of MSNs, it is difficult to determine not only the DA
receptor sub-type involved but also the exact locus of the cocaine-dependent suppression of excitatory
signaling.
Numerous studies have demonstrated that cocaine-induced changes in excitatory signaling occur
almost exclusively at D1-MSN synapses (Kim et al., 2011, Lobo and Nestler, 2011, Pascoli et al., 2014,
Terrier et al., 2016), suggesting that observed reductions in synaptic signaling occur in D1-MSNs.
However, it is unlikely that this involves direct activation of DA receptors on D1R-MSNs, as D1R
stimulation has been shown to increase AMPAR surface expression and AMPAR-mediated currents in
MSNs (Chao et al., 2002, Price et al., 1999, Sun et al., 2008). Conversely, activation of presynaptic D1
receptors is known to reduce excitatory postsynaptic potentials in striatal MSNs, indicating that any
effects of D1R activation are likely localized to presynaptic signaling (Harvey and Lacey, 1996, Nicola
and Malenka, 1997).
Another intriguing possibility is that reductions in AMPAR signaling reflect suppression of baseline
excitatory signaling primarily at D2R-MSN, rather than reversal of plasticity at D1R-MSN synapses –
presumably through direct activation of D2R signaling. In agreement with this, D2R activation reduces
basal and agonist-induced AMPAR signaling in striatal MSNs (André et al., 2010, Hernández-Echeagaray
et al., 2004, Håkansson et al., 2006, Snyder et al., 2000). Moreover, in agreement with a role for
suppressed excitatory signaling in driving addiction-related behavior, recent findings suggest that
cocaine-induced reinstatement is associated with a reduction in excitatory signaling specifically in NAc
shell D2R-expressing MSNs (Ortinski et al., 2015). This reduction at D2-MSN synapses would
theoretically shift the ratio of excitatory drive at D1R-versus D2R-MSN circuits in favor of D1R signaling
– a possibility that fits well with the ventral striatal D1 pathway in behavior and reward, as well as
emerging theories on circuit-based plasticity responsible for relapse (Dobi et al., 2011, Graziane et al.,
2016, Hearing et al., 2016, Kim et al., 2011, Lobo and Nestler, 2011, Ortinski et al., 2015, Ortinski et al.,
2012, Pascoli et al., 2011, Smith et al., 2013, Suska et al., 2013). Regardless, our findings indicate that
endogenous dopamine signaling plays a critical role in modifying NAc synapses potentiated by previous
cocaine experience, and may provide a mechanism for developing therapeutic strategies.

4.3. CB1 receptors mediate synaptic depotentiation in the NAc shell
Within the striatum, eCB signaling is a critical regulator of synaptic activity and plasticity, facilitating
synaptic depression at glutamatergic synapses on MSNs through CB1 receptor-mediated suppression

of excitatory transmission (Gerdeman et al., 2002, Kreitzer and Malenka, 2007, Robbe et al., 2002).
Furthermore, accumulating evidence indicates a critical role for eCB signaling in reward-related
behavior and facilitation of excitatory synaptic plasticity in the striatum (Wiskerke et al., 2008, Zlebnik
and Cheer, 2016). Blocking CB1 receptors reduces the rewarding and reinforcing properties of cocaine
(Orio et al., 2009, De Vries et al., 2001, Xi et al., 2006), indicating that CB1 activity potently regulates
behavioral sensitivity to cocaine. Given the fundamental role that eCBs play in dampening excitatory
signaling throughout the striatum, eCB signaling mechanisms might be engaged by cocaine re-exposure
to mediate cocaine-induced depotentiation of synaptic strength in the NAc shell. While evidence of the
impact of repeated cocaine on eCB-mediated signaling and synaptic plasticity in the NAc is still
relatively limited, several studies previously suggested that eCB-mediated plasticity in the striatum is
impaired by acute cocaine (Fourgeaud et al., 2004, Grueter et al., 2010). However, more recent work
demonstrated that CB1 signaling remains functionally intact following repeated cocaine (McCutcheon
et al., 2011, Ortinski et al., 2012). In the present study, we observed that application of the CB1
receptor antagonist/inverse agonist SR141716A prevented the cocaine-induced reduction in mEPSC
frequency while partially rescuing the challenge-induced reduction in mEPSC amplitude. Additionally,
we found that activation of CB1 receptors with the agonist WIN 55,212-2 was sufficient to
depotentiate both mEPSC amplitude and frequency. These findings confirm that CB1 signaling remains
functionally intact following repeated cocaine and is capable of modulating glutamatergic synaptic
plasticity in the NAc shell.
To our knowledge, our data are the first to report that CB1 signaling modifies post-synaptic AMPAR
signaling during protracted abstinence from cocaine. The ability of the CB1 agonist WIN 55,212-2 to
induce alterations in both mEPSC frequency and amplitude is surprising given the pre-synaptic
localization of these receptors on glutamatergic afferents in the NAc. However, there is some evidence
that WIN 55,212-2 is capable of depressing mEPSC amplitude and frequency in the NAc under basal
(non-drug) conditions (Hoffman and Lupica, 2001). Additionally, endogenous and exogenous
cannabinoid ligands have been shown to alter post-synaptic signaling properties by modulating a
number of ionic conductances (Deadwyler et al., 1995, Mackie et al., 1995, Schweitzer, 2000) or other
non-CB1 targets such as post-synaptic TRPV1 receptors (Grueter et al., 2010). Furthermore, it is
relatively unknown how repeated cocaine exposure influences these complex eCB signaling
mechanisms. Additional studies will be needed to elucidate how CB1 receptor activation is capable of
broadly modulating both pre- and post-synaptic glutamatergic transmission in the NAc following
experience with cocaine.
Given that striatal CB1 signaling plays a central role in synaptic depression at glutamatergic synapses,
our data suggests that cocaine re-exposure during abstinence engages similar CB1 signaling
mechanisms that promote a reduction in glutamatergic synaptic transmission at NAc MSN synapses.
CB1 signaling in the NAc therefore might participate in reducing excitatory synaptic strength by
interacting with a number of potential cellular mechanisms. A substantial body of evidence has
demonstrated that eCB-mediated depression of glutamatergic transmission in the striatum commonly
requires activation of Group I mGluRs (mGluR1 and mGluR5) (Lüscher and Huber, 2010). Activation of
post-synaptic mGluR1/5 on NAc MSNs promotes the release of eCBs, which activate pre-synaptic CB1
receptors to decrease pre-synaptic release probability and promote synaptic depression (Castillo et al.,
2012, Robbe et al., 2002). Enhanced glutamatergic synaptic transmission in the NAc elicited by re-

exposure to cocaine (McFarland et al., 2003, Park et al., 2002) may therefore activate mGluR1/5 and
initiate eCB signaling, promoting a reduction in synaptic strength. Previously, our lab demonstrated
that mGluR5 signaling in the NAc shell is necessary for cocaine-induced AMPAR synaptic
depotentiation (Jedynak et al., 2016). Our data here showing that synaptic depotentiation requires CB1
receptor activity in the NAc shell could reflect serial activation of mGluR5 and CB1 receptors that
participate in reducing glutamatergic synaptic transmission in the NAc shell following cocaine reexposure.
Dopamine D2 receptors have been shown to cooperate with Group I mGluRs to promote eCB signaling
and excitatory synaptic depression in the striatum (Kreitzer and Malenka, 2005, Yin and Lovinger,
2006). Glutamatergic synapses onto D2 receptor-expressing MSNs in the striatum preferentially
express eCB-mediated LTD compared to D1-MSNs (Grueter et al., 2010, Kreitzer and Malenka, 2007),
and several studies have reported a requirement for D2 receptor activation in striatal eCB-LTD (Kreitzer
and Malenka, 2007, Shen et al., 2008, Wang et al., 2006). A potential explanation for this phenomenon
is that D2 receptor activation facilitates eCB production in the striatum (Centonze et al., 2004, Giuffrida
et al., 1999, Patel et al., 2003, Wang et al., 2006), and therefore may cooperate with Group I mGluRs to
promote eCB-mediated synaptic depression. Increased synaptic availability of dopamine elicited by
cocaine re-exposure may therefore promote eCB signaling preferentially through D2 receptor
activation in MSNs of the NAc shell. While additional studies are needed to determine the cell typeand receptor type-specific mechanisms by which cocaine re-exposure engages both dopamine and eCB
signaling mechanisms to modify glutamatergic synaptic plasticity, our findings demonstrate that the
eCB system participates in attenuating potentiated AMPAR synaptic transmission during re-exposure
to cocaine. Given that increasing clinical evidence suggests that an interaction between both the
dopamine and eCB systems is involved in the pathophysiology of numerous limbic-based disorders
involving the striatum, (García et al., 2016, Kuepper et al., 2010, Parolaro and Rubino, 2008, Pisani
et al., 2011), understanding the complex interactions between these two systems may be critical in
developing future therapeutic strategies for relapse.

5. Conclusion
These studies broadly demonstrate that dopamine and endocannabinoid signaling in the NAc can have
diverse effects on AMPAR-mediated synaptic function depending on previous psychostimulant
experience. Here, we examined mechanisms underlying the depotentiation of AMPAR-mediated
synaptic transmission in the NAc shell evoked by cocaine re-exposure, finding that plasticity is rapidly
induced and persists for up several days before returning to “repotentiated” levels, suggesting that
synapses altered by cocaine exposure remain plastic and are capable of undergoing further
modifications by re-exposure to cocaine. Both dopamine and eCBs, critical modulators of synaptic
plasticity in the NAc, contribute to AMPAR synaptic depotentiation, indicating that cocaine re-exposure
engages multiple signaling pathways in the NAc that cooperate in modifying excitatory synaptic
strength. Alterations in glutamatergic synaptic transmission induced by experience with cocaine may
therefore profoundly alter the responsiveness of MSNs to future stimulation by dopamine, modifying
dopamine's capacity to effectively gate activity and plasticity at glutamatergic synapses. Additionally,
changes in dopamine receptor expression and signaling during abstinence or extinction (Anderson and

Pierce, 2005) may modify how dopamine and glutamate receptor signaling mechanisms converge and
interact at an intracellular level. Endocannabinoid signaling may additionally modulate MSN
responsiveness to alterations in glutamatergic signaling induced by cocaine experience. Further studies
will be needed to determine the cellular signaling factors mediating the complex effects of these
critical neuromodulators on cocaine-induced AMPAR plasticity.
These signaling mechanisms may gate the induction of plasticity at inputs to the NAc by converging on
common factors that drive alterations in MSN excitability and plasticity and ultimately drive addictionrelated behavior, providing targetable mechanisms for developing therapeutic strategies.
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